Piramal Pharma’s arm completes acquisition of ‘Kenalog’

01 Apr 2026 Evaluate

Piramal Pharma’s step-down wholly owned subsidiary -- Piramal Critical Care B.V. has successfully completed the acquisition of ‘Kenalog’ and its associated brands from Bristol-Myers Squibb Company (BMS).

With the completion of the Kenalog acquisition, the Company strengthens its Complex Hospital Generics portfolio and reinforces its presence across key markets including the United States, Europe, and Asia Pacific.

Piramal Pharma provides end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network.

Piramal Pharma Share Price

136.90 -5.85 (-4.10%)
02-Apr-2026 09:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1645.15
Dr. Reddys Lab 1180.55
Cipla 1172.65
Zydus Lifesciences 838.85
Lupin 2189.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×